image

The best stocks to buy since 1993

Latest issue now available

Abcam - Growing sales like topsy

January 2006

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ABC
  • Price:
  • 254p
In an apparent flashback to the dotcom days, there have been sharp moves in shares of some of the online retailers. This time round, however, companies are backed by solid profitability. One such is Cambridge-based Abcam (ABC; 254p) which sells antibodies to scientists. As any schoolboy will tell you, antibodies are proteins produced by mammals in response to a foreign body and their ability to recognise and bind to certain types of molecules makes them one of the mainstays of biological research. Abcam is the brainchild of Jonathan Milner who whilst carrying out research on breast cancer had become frustrated at the difficulty in sourcing antibodies and a lack of reliable information about their uses and limitations. Milner est ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe